Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Abbott to pay $3.72bn for Piramal's branded generics business

Executive Summary

In a transaction that will make it the leading pharma company in India with a 7% market share, Abbott Laboratories Inc. is acquiring Piramal Healthcare Ltd.'s healthcare solutions business for $2.12bn up front, plus $400mm annually for the next four years starting in 2011.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Contract

Related Companies

Advertisement
UsernamePublicRestriction

Register